Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
COP Coated Vesicles00:59

COP Coated Vesicles

12.6K
Membrane-enclosed structures called vesicles transport proteins and lipids across the cell. The vesicles derive their cargo from the plasma membrane, Golgi, ER, or endosome. Coated vesicles are spherical, protein-coated carriers with a 50–100 nm diameter that mediate bidirectional transport between the ER and the Golgi. The distribution of proteins between the ER and Golgi complex is dynamic and is maintained by different coated vesicles. Their formation is driven by the assembly of...
12.6K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

105.4K
Overview
105.4K
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KIF7 promotes the proliferation of clear cell renal cell carcinoma by activating the WNT/β-catenin signaling pathway.

Clinical and experimental medicine·2026
Same author

Induction chemotherapy prior to definitive chemoradiotherapy in locally advanced cervical cancer patients: A multi-center cohort study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Evolution of artificial intelligence in breast cancer pathology: a bibliometric analysis.

Discover oncology·2026
Same author

WTAP-mediated m6A modification of UBE2K drives the malignant progression of gastric cancer.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

Astrocytes and Microglia Regulate Opioid Receptor-Driven Cancer Brain Metastasis and Neural Injury: Remodeling the Brain Microenvironment.

Journal of inflammation research·2026
Same author

Ingrilimine, a novel marine cytotoxic and apoptotic cyclic imine toxin with a high affinity and dual activity on human α7 nicotinic acetylcholine receptor.

Chemosphere·2026

Related Experiment Video

Updated: Apr 30, 2026

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.3K

Reduction-responsive cholesterol-based block copolymer vesicles for drug delivery.

Lin Jia1, Di Cui, Jérôme Bignon

  • 1Institut Curie, Centre de Recherche, 75248 Paris, France.

Biomacromolecules
|May 8, 2014
PubMed
Summary

Researchers created robust, reduction-responsive polymersomes using PEG-SS-PAChol copolymers. These novel drug carriers exhibit stability and triggered release in response to glutathione (GSH), offering potential for long circulation times.

More Related Videos

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
10:53

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Published on: October 10, 2016

12.8K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K

Related Experiment Videos

Last Updated: Apr 30, 2026

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

8.3K
Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
10:53

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions

Published on: October 10, 2016

12.8K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K

Area of Science:

  • Polymer Chemistry
  • Materials Science
  • Nanotechnology

Background:

  • Development of stimuli-responsive drug delivery systems is crucial for targeted therapies.
  • Polymersomes offer advantages as nanocarriers due to their tunable properties and biocompatibility.
  • Robust and stable drug carriers with controlled release mechanisms are highly sought after.

Purpose of the Study:

  • To synthesize and characterize a novel reduction-responsive polymersome system.
  • To investigate the stability and triggered disassembly of these polymersomes in response to reducing agents.
  • To evaluate the potential of these polymersomes as drug carriers with controlled release kinetics.

Main Methods:

  • Synthesis of amphiphilic block copolymers (PEG-SS-PAChol) via atom transfer radical polymerization (ATRP).
  • Formation and characterization of polymersomes.
  • Investigation of disulfide bond cleavage using organic solutions and cryo-electron microscopy.
  • Assessment of calcein release triggered by glutathione (GSH) in PBS and macrophage cells.

Main Results:

  • Successfully synthesized robust reduction-responsive polymersomes (PEG-SS-PAChol).
  • Demonstrated polymersome disassembly upon reductive cleavage of disulfide bonds.
  • Observed triggered release of calcein payload by glutathione (GSH), requiring high concentrations and incubation times.
  • Confirmed in vitro release within macrophage cells.

Conclusions:

  • The developed PEG-SS-PAChol polymersomes are stable and robust, with triggered disassembly in response to reduction.
  • These polymersomes show potential as drug carriers with long circulation profiles and slow release kinetics.
  • Further optimization may be needed to enhance release rates for specific therapeutic applications.